Carolina Gallego-Marin
Research Subjects
Research Interests
Carolina Gallego-Marin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alvaro Mauricio Lasso
Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) , Cali
1 shared publication - Douglas Taylor Golenbock
Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
1 shared publication - Evelyn A. Kurt-Jones
Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
1 shared publication Jacob E Schrum
Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605
1 shared publication- Katherine A. Fitzgerald
Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
1 shared publication - Lina Giraldo-Parra
Centro Internacional de Entrenamiento e Investigaciones Médicas
1 shared publication
Latest Publications
- 15 January 2018
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 200 (2) , 768-774
Cyclic GMP–AMP Synthase Is the Cytosolic Sensor of Plasmodium falciparum Genomic DNA and Activates Type I IFN in Malaria
Innate immune receptors have a key role in the sensing of malaria and initiating immune responses. As a consequence of infection, systemic inflammation emerges and is directly related to signs and symptoms during acute disease. We have previously reported that plasmodial DNA is the primary driver of systemic inflammation in malaria, both within the phagolysosome and in the cytosol of effector cells. In this article, we demonstrate that Plasmodium falciparum genomic DNA delivered to the cytosol of human monocytes binds and activates cyclic GMP–AMP synthase (cGAS). Activated cGAS synthesizes 2′3′-cGAMP, which we subsequently can detect using liquid chromatography–tandem mass spectrometry. 2′3′-cGAMP acts as a second messenger for STING activation and triggers TBK1/IRF3 activation, resulting in type I IFN production in human cells. This induction of type I IFN was independent of IFI16. Access of DNA to the cytosolic compartment is mediated by hemozoin, because incubation of purified malaria pigment with DNase abrogated IFN-β induction. Collectively, these observations implicate cGAS as an important cytosolic sensor of P. falciparum genomic DNA and reveal the role of the cGAS/STING pathway in the induction of type I IFN in response to malaria parasites.
- 15 January 2018
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 200 (2) , 768-774
Cyclic GMP–AMP Synthase Is the Cytosolic Sensor of Plasmodium falciparum Genomic DNA and Activates Type I IFN in Malaria
Innate immune receptors have a key role in the sensing of malaria and initiating immune responses. As a consequence of infection, systemic inflammation emerges and is directly related to signs and symptoms during acute disease. We have previously reported that plasmodial DNA is the primary driver of systemic inflammation in malaria, both within the phagolysosome and in the cytosol of effector cells. In this article, we demonstrate that Plasmodium falciparum genomic DNA delivered to the cytosol of human monocytes binds and activates cyclic GMP–AMP synthase (cGAS). Activated cGAS synthesizes 2′3′-cGAMP, which we subsequently can detect using liquid chromatography–tandem mass spectrometry. 2′3′-cGAMP acts as a second messenger for STING activation and triggers TBK1/IRF3 activation, resulting in type I IFN production in human cells. This induction of type I IFN was independent of IFI16. Access of DNA to the cytosolic compartment is mediated by hemozoin, because incubation of purified malaria pigment with DNase abrogated IFN-β induction. Collectively, these observations implicate cGAS as an important cytosolic sensor of P. falciparum genomic DNA and reveal the role of the cGAS/STING pathway in the induction of type I IFN in response to malaria parasites.